Trials / Recruiting
RecruitingNCT06662448
Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies
An Open-Label Study to Evaluate the Efficacy and Feasibility of Home-Based Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to test the efficacy and feasibility of an intervention protocol for home-based repetitive transorbital alternating current stimulation (rtACS) for the treatment of visual impairment in people with optic neuropathy. The primary aims are to evaluate the effectiveness of home-based rtACS to ameliorate the progressive effects of vision loss functionally in the eye and the visual pathway, and in regard to people's independence (i.e., functional ability).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SAVIR Alpha Synch mobile (SASm) | The SAVIR Alpha Synch mobile is a device first used in office and then intended to be used for the home therapy of the visual system with non-invasive electrical stimulation. |
Timeline
- Start date
- 2024-11-18
- Primary completion
- 2029-05-18
- Completion
- 2029-05-18
- First posted
- 2024-10-29
- Last updated
- 2026-02-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06662448. Inclusion in this directory is not an endorsement.